You are here: Industry Insights > U.S.

News List

Moleculin Receives FDA Approval of Fast Track Designation for Annamycin americanpharmaceuticalreview
April 19, 2019
Moleculin Biotech announced that the U.S. Food and Drug Administration (FDA) has approved its request for Fast Track Designation for its drug, Annamycin, for the treatment of relapsed or refractory acute myeloid leukemia (AML).
Sixty People Charged in Massive Opioid Painkiller Investigation drugs
April 19, 2019
Sixty People Charged in Massive Opioid Painkiller Investigation.
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. americanpharmaceuticalreview
April 18, 2019
TherapeuticsMD announced the commercial availability of BIJUVATM (estradiol and progesterone capsules, 1 mg/100 mg) in the United States.
Sun Pharma launches INFUGEM in the U.S. biospectrumasia
April 08, 2019
India-based Sun Pharmaceutical Industries Ltd. has announced that INFUGEM……
U.S. government forces Chinese divestiture in health data startup PatientsLikeMe: report fiercepharma
April 08, 2019
Real-world data gatherer PatientsLikeMe has to shop for a new buyer—and quickly—after the Trump administration ordered a Chinese company to divest its majority stake, according to a report from CNBC.
WuXi AppTec Testing Facilities Complete Inspections contractpharma
March 12, 2019
Sites in Suzhou and Shanghai receive CNAS and OECD GLP accreditation
U.S. Medical Schools See Increase in Diversity drugs
December 12, 2018
After implementation of the Liaison Committee on Medical Education (LCME) diversity accreditation standards, U.S. medical schools saw increasing percentages of female....
Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children drugs
December 04, 2018
The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics....
Cellect Granted Key European Patent for Its Stem Cell Selection Technology biospectrumasia
November 23, 2018
Through negative selection, Cellect's technology identifies mature cells that can be harmful to the recipient and selectively eliminates those cells through apoptosis (cell death).
FDA approves new drug to treat influenza fda
November 09, 2018
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older

Previous page 1 2 3 4 5 6 Next page